
ANEBULO PHARMAC INC by Anebulo Pharmaceuticals fell 88.0% from $2.33 to $0.28, behind the S&P 500's +10.6%. Its worst day was Jul 15 (−99.9%), and its low came Jul 15 at $0.00.
Nov 18, 2025 – Nov 18, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
ANEBULO PHARMAC INC by Anebulo Pharmaceuticals closed at its highest level of the year, 6.9% above where the year started.
+5.2% · S&P 500 +0.9%
EPS of $-0.05 beat the $-0.13 estimate on $0.00 revenue.
Story events cover the past 12 months · Times ET
+0.9% · S&P 500 +0.1%
ANEBULO PHARMAC INC by Anebulo Pharmaceuticals closed at its lowest level of the year, 100.0% below where the year started.
−99.9%, the year's worst day · S&P 500 +0.4%
ANEBULO PHARMAC INC by Anebulo Pharmaceuticals shares rose 42042.9%, while the S&P 500 rose 0.3%.
+42042.9% · S&P 500 +0.3%
Where it ended: a close of $0.28 on Nov 18, 2026.
Nothing in the past 12 months.
All ANEB analyst actionsNothing in the past 12 months.
All ANEB dividend history